Nuvation Bio Inc
NYSE:NUVB
Cash Flow Statement
Cash Flow Statement
Nuvation Bio Inc
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
(51)
|
(38)
|
(42)
|
(53)
|
(64)
|
(75)
|
(87)
|
(88)
|
(103)
|
(108)
|
(104)
|
(105)
|
(90)
|
(83)
|
(76)
|
(69)
|
(511)
|
(532)
|
(568)
|
(606)
|
(203)
|
(217)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
0
|
2
|
4
|
6
|
9
|
9
|
11
|
14
|
14
|
16
|
18
|
18
|
21
|
20
|
20
|
24
|
26
|
32
|
35
|
38
|
38
|
|
| Other Non-Cash Items |
5
|
2
|
3
|
8
|
10
|
13
|
12
|
5
|
7
|
7
|
12
|
15
|
13
|
11
|
7
|
8
|
437
|
440
|
449
|
453
|
32
|
39
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
6
|
4
|
2
|
3
|
2
|
4
|
7
|
4
|
7
|
(2)
|
(4)
|
(1)
|
(4)
|
3
|
1
|
(4)
|
(11)
|
(8)
|
(13)
|
(5)
|
1
|
(12)
|
|
| Cash from Operating Activities |
(40)
N/A
|
(33)
+18%
|
(37)
-11%
|
(43)
-16%
|
(53)
-24%
|
(58)
-10%
|
(68)
-18%
|
(78)
-15%
|
(88)
-13%
|
(103)
-17%
|
(96)
+7%
|
(91)
+6%
|
(81)
+10%
|
(69)
+15%
|
(68)
+2%
|
(64)
+5%
|
(84)
-31%
|
(99)
-18%
|
(130)
-32%
|
(157)
-21%
|
(168)
-7%
|
(190)
-13%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(8)
|
|
| Other Items |
(94)
|
36
|
(70)
|
(82)
|
(265)
|
(364)
|
(454)
|
(459)
|
(260)
|
(104)
|
64
|
17
|
28
|
(46)
|
9
|
69
|
65
|
104
|
123
|
170
|
190
|
72
|
|
| Cash from Investing Activities |
(94)
N/A
|
35
N/A
|
(70)
N/A
|
(82)
-17%
|
(265)
-224%
|
(364)
-37%
|
(455)
-25%
|
(459)
-1%
|
(260)
+43%
|
(104)
+60%
|
63
N/A
|
17
-73%
|
28
+63%
|
(46)
N/A
|
9
N/A
|
68
+667%
|
65
-4%
|
104
+59%
|
123
+18%
|
169
+38%
|
190
+12%
|
64
-66%
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
1
|
136
|
0
|
136
|
135
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
2
|
4
|
5
|
6
|
5
|
4
|
|
| Net Issuance of Debt |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
(2)
|
(5)
|
(5)
|
43
|
46
|
|
| Other |
0
|
0
|
(3)
|
622
|
622
|
622
|
625
|
4
|
(0)
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
143
|
143
|
|
| Cash from Financing Activities |
0
N/A
|
0
N/A
|
133
+51 108%
|
758
+469%
|
758
+0%
|
758
0%
|
626
-17%
|
5
-99%
|
1
-76%
|
1
+25%
|
1
-9%
|
(3)
N/A
|
1
N/A
|
1
-16%
|
1
-32%
|
0
-44%
|
3
+750%
|
1
-55%
|
0
-75%
|
1
+159%
|
192
+22 223%
|
194
+1%
|
|
| Change in Cash | |||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
1
|
0
|
1
|
|
| Net Change in Cash |
9
N/A
|
2
-73%
|
26
+969%
|
634
+2 310%
|
440
-31%
|
336
-24%
|
103
-69%
|
(533)
N/A
|
(347)
+35%
|
(206)
+41%
|
(31)
+85%
|
(76)
-143%
|
(52)
+31%
|
(114)
-119%
|
(58)
+49%
|
4
N/A
|
(16)
N/A
|
6
N/A
|
(7)
N/A
|
13
N/A
|
214
+1 487%
|
69
-68%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
(41)
N/A
|
(33)
+18%
|
(37)
-10%
|
(43)
-16%
|
(53)
-23%
|
(58)
-10%
|
(68)
-18%
|
(79)
-15%
|
(89)
-13%
|
(104)
-17%
|
(96)
+7%
|
(91)
+6%
|
(81)
+11%
|
(69)
+15%
|
(68)
+2%
|
(64)
+5%
|
(84)
-31%
|
(99)
-18%
|
(131)
-31%
|
(158)
-21%
|
(169)
-7%
|
(198)
-18%
|
|